Livingston-based prosthetic technology specialist, Össur, has secured a £400,000 research and development grant from Scottish Enterprise, as part of a £2 million project aimed at advancing upper limb prosthetic technologies.
A Scottish Government-backed delegation is travelling to Norway this week to showcase the strength of the country’s aquaculture supply chain and boost international trade opportunities for SMEs.
Glasgow-based integrated drug formulation and clinical trials specialist BDD has secured a fresh £2 million investment to fuel its expansion, responding to a surge in demand for its proprietary drug delivery technology and its niche clinical trial services.
Edinburgh-based life science firm, Cytomos, has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology.
Scottish health tech firm Emblation has unveiled its new £4 million state-of-the-art headquarters located in Stirling, marking a significant milestone in the firm’s global expansion journey.
Emblation, the Alloa-based health-tech innovator is undertaking a rigorous clinical trial which could transform the fortunes of its microwave treatments in the US.
Sir Tom Hunter, through West Coast Capital (WCC), the investment arm of the Hunter family, has made a multi-million-pound contribution to Ellipses Pharma, an innovative cancer drug venture.
St Andrews-based biotech firm Pneumagen has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).
German science and technology giant, Merck, has announced plans to invest €35 million (£30m) in the expansion of its biosafety testing capabilities in Glasgow and Stirling.
Edinburgh-based Lentitek Ltd, a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment. This investment will be deployed to further advance its technology and commence initial commercial trials.
The Sustainable Aquaculture Innovation Centre (SAIC) has announced support for a further six innovation projects valued at £2.5 million, taking its total investment in research and development initiatives to 100 projects.